www.fdanews.com/articles/142962-fda-grants-fast-track-status-to-achillion-ach-1625-drug

FDA Grants Fast Track Status to Achillion ACH-1625 Drug

January 5, 2012

Achillion Pharmaceuticals’s ACH-1625 drug has been granted fast track designation by the FDA for the treatment of chronic hepatitis C virus.
Pharmaceutical Business Review